FDA RECALL NOTIFICATION: IV Solution by Walli-Practi Used for Educational, Training Purposes Recalled

Contact:
Consumer:
619-702-4333

1fda

FOR IMMEDIATE RELEASE — January 7, 2015 — San Diego, CA — This letter is to notify you of a product recall involving Wallcur’s Practi-0.9‰ sodium chloride IV bags supplied in 50 mL, 250 mL, 500, mL, and 1000 mL sizes and the Practi-0.9‰ sodium chloride 100 mL IV solution bag with sterile distilled water.

As you know, all of Wallcur’s products are intended for training, simulation, and educational purposes only. Recently some of Wallcur’s training products were not used for their intended purpose. Specifically, despite the fact that the products are intended “for clinical simulation” only, we are aware of reports that these products have been used outside of their intended use and administered to patients. Because these products are not intended for human or animal administration, and are not sterile, administration of these products could result in adverse events.

We began shipping this product on May 22, 2014. Immediately examine your inventory, quarantine the products subject to recall, and return them to Wallcur. In addition, if you are a Wallcur distributor, or have further distributed or sold this product, please provide Wallcur with a list of your customers the products were distributed or sold to, and notify them at once of this product recall. Your notification to your customers may be enhanced by including a copy of this recall notification letter along with a copy of the enclosed product labels to make the products easily identifiable at the user level. Please also notify your customers that have purchased these products that the products are for demonstration, training, and educational purposes only, and not for human or animal use.

Your assistance is appreciated and necessary to prevent use of these products in humans or animals. Please complete and return the enclosed response form as soon as possible. If you have any questions call Carla Sanderson at 619-702-4333.

This recall is being carried out with the knowledge of the U.S. Food and Drug Administration.

In addition to the recall, as a precautionary measure, if you are a Wallcur distributor or reseller, we are requesting that you ensure your websites, catalogues, and other print materials advertising these products and any other Wallcur products prominently display the following language:

“THIS PRODUCT IS FOR TRAINING PURPOSES ONLY. NOT FOR HUMAN OR ANIMAL INJECTION.“

Wallcur intends to add product enhancement labels containing similar language to the IV bags prior to future distribution.

REPOSTED from FDA.gov

2015 The NW Fire Blog